MDS 2021 | The future of imaging in Parkinson’s disease

Sofia Reimão, MD, University of Lisbon, Lisbon, Portugal, shares her thoughts on some of the major areas of neuroimaging research in Parkinson’s disease (PD). Artificial intelligence is a prominent focus in the space. As imaging techniques advance and more and more data can be routinely collected, methods to record and analyze this increasingly complex data must be develop at the same pace. Artificial intelligence has the potential to help manage this information. Additionally, deep learning techniques may be useful for identifying optimal parameter combinations for differential diagnosis and improved prognostication. This interview took place during the 2021 International Congress of Parkinson’s Disease and Movement Disorders.